Olivier Danos Regenxbio Inc. (RGNX) insider trading activity

RGNX Quotes by TradingView

Olivier Danos is Chief Scientific Officer of REGENXBIO Inc.. Currently has a direct ownership of 86,391 shares of RGNX, which is worth approximately $941,661. The most recent transaction as insider was on Jan 02, 2024, when has been sold 8,410 shares (Common Stock) at a price of $17.95 per share, resulting in proceeds of $150,959. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.4K
0% 3M change
8.87% 12M change
Total Value Held $941,661

Olivier Danos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
SELL
Payment of exercise price or tax liability
$150,959 $17.95 p/Share
8,410 Reduced 8.87%
86,391 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
38,462 Added 23.55%
124,853 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
$19,079 $16.99 p/Share
1,123 Added 1.17%
94,801 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$46,675 $22.68 p/Share
2,058 Reduced 7.08%
27,020 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
65,930 Added 41.5%
92,950 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
$15,288 $21.0 p/Share
728 Added 0.77%
93,678 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
10,700 Added 26.9%
29,078 Common Stock
Jan 01 2022
SELL
Payment of exercise price or tax liability
$39,927 $32.7 p/Share
1,221 Reduced 6.23%
18,378 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$28 $27.8 p/Share
1 Added 0.01%
19,599 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$18,326 $33.02 p/Share
555 Added 2.75%
19,598 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
11,600 Added 37.86%
19,043 Common Stock
Jun 30 2020
BUY
Grant, award, or other acquisition
$20,070 $31.31 p/Share
641 Added 7.93%
7,443 Common Stock
Dec 31 2019
BUY
Grant, award, or other acquisition
$10,516 $34.82 p/Share
302 Added 4.25%
6,802 Common Stock
OD

Olivier Danos

Chief Scientific Officer
Rockville, MD

Track Institutional and Insider Activities on RGNX

Follow REGENXBIO Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGNX shares.

Notify only if

Insider Trading

Get notified when an Regenxbio Inc. insider buys or sells RGNX shares.

Notify only if

News

Receive news related to REGENXBIO Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGNX